Disease | cystic fibrosis |
Symptom | C2350529|pulmonary aspergillosis |
Sentences | 21 |
PubMedID- 24167019 | Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: a synthesis of published evidence. |
PubMedID- 22448043 | Airway colonization with aspergillus causes allergic bronchopulmonary aspergillosis (abpa) in patients with cystic fibrosis or chronic asthma. |
PubMedID- 25015245 | Role of omalizumab in the management of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. |
PubMedID- 25010610 | Anti ige antibody as treatment of allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis. |
PubMedID- 25431975 | Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. |
PubMedID- 24043500 | Selection criteria: randomized and quasi-randomized controlled trials comparing anti-ige therapy to placebo or other therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. |
PubMedID- 26003072 | Aim: to establish the prevalence of pulmonary aspergillosis in children with cystic fibrosis under the care of our centre and to investigate the potential predisposing factors to aspergillus infection (ai) and allergic bronchopulmonary aspergillosis (abpa). |
PubMedID- 22731696 | It is conceivable that high il-10 levels could contribute to the resolution of the aspergillus induced pulmonary inflammation, but high il-10 concentrations have also been associated with development of invasive aspergillosis in non-neutropenic immunocompromised patients and with colonization with a. fumigatus and allergic bronchopulmonary aspergillosis in patients with cystic fibrosis . |
PubMedID- 20597074 | Risk factors for aspergillus colonization and allergic bronchopulmonary aspergillosis in children with cystic fibrosis. |
PubMedID- 24248318 | Early diagnosis and treatment of invasive pulmonary aspergillosis in a patient with cystic fibrosis. |
PubMedID- 22696329 | Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. |
PubMedID- 23278646 | Hla-drb1 and hla-dqb1 genes on susceptibility to and protection from allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. |
PubMedID- 21067334 | Serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis: state of the art and further challenges. |
PubMedID- 22608296 | Blood basophils from cystic fibrosis patients with allergic bronchopulmonary aspergillosis are primed and hyper-responsive to stimulation by aspergillus allergens. |
PubMedID- 23278535 | Immune response, diagnosis and treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis lung disease. |
PubMedID- 20127304 | Typical acute complications are infective exacerbations - the most frequent cause of death in cystic fibrosis - along with allergic bronchopulmonary aspergillosis, haemoptyses and pneumothoraces. |
PubMedID- 20714107 | Vitamin d3 attenuates th2 responses to aspergillus fumigatus mounted by cd4+ t cells from cystic fibrosis patients with allergic bronchopulmonary aspergillosis. |
PubMedID- 25705310 | Allergic bronchopulmonary aspergillosis in patient with cystic fibrosis - a case report. |
PubMedID- 25354514 | Allergic bronchopulmonary aspergillosis affects patients with asthma and cystic fibrosis, and is important to recognise as permanent lung or airways damage may accrue if untreated. |
PubMedID- 25150265 | Omalizumab: a new treatment option for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. |
PubMedID- 26187954 | Allergic bronchopulmonary aspergillosis affects patients with asthma and cystic fibrosis, and is important to recognise as permanent lung or airways damage may accrue if untreated. |
Page: 1